Abstract
The effect of intravenous somatostatin infusion was investigated in a patient with severe secretory diarrhea due to malignant carcinoid syndrome. Continuous somatostatin infusion for 48 hr (4 μg/kg/hr) reduced stool volume from 2.2 to 0.7 liters/day. Intestinal perfusion studies before intravenous somatostatin infusion revealed decreased water and sodium absorption and jejunal chloride secretion. Somatostatin infusion for 2 hr (8 μg/kg/hr) reversed chloride secretion to absorption and markedly enhanced water and sodium absorption. These results suggest that somatostatin inhibited a secretory component of water and ion movement in the small bowel of the patient with malignant carcinoid syndrome.
Original language | English (US) |
---|---|
Pages (from-to) | 346-349 |
Number of pages | 4 |
Journal | Gastroenterology |
Volume | 78 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1980 |
ASJC Scopus subject areas
- Hepatology
- Gastroenterology